BrainsWay Statistics
Total Valuation
BrainsWay has a market cap or net worth of $214.86 million. The enterprise value is $164.47 million.
Important Dates
The next estimated earnings date is Wednesday, March 5, 2025, before market open.
| Earnings Date | Mar 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BrainsWay has 33.10 million shares outstanding. The number of shares has increased by 1.64% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 33.10M |
| Shares Change (YoY) | +1.64% |
| Shares Change (QoQ) | +10.33% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 24.09M |
Valuation Ratios
The trailing PE ratio is 143.24 and the forward PE ratio is 64.14.
| PE Ratio | 143.24 |
| Forward PE | 64.14 |
| PS Ratio | 5.56 |
| Forward PS | 1.20 |
| PB Ratio | 4.88 |
| P/TBV Ratio | 4.88 |
| P/FCF Ratio | 36.02 |
| P/OCF Ratio | 23.16 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 72.07, with an EV/FCF ratio of 27.57.
| EV / Earnings | 109.64 |
| EV / Sales | 4.26 |
| EV / EBITDA | 72.07 |
| EV / EBIT | 143.76 |
| EV / FCF | 27.57 |
Financial Position
The company has a current ratio of 4.52
| Current Ratio | 4.52 |
| Quick Ratio | 4.07 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0.68 |
Financial Efficiency
Return on equity (ROE) is 3.52% and return on invested capital (ROIC) is 1.68%.
| Return on Equity (ROE) | 3.52% |
| Return on Assets (ROA) | 1.08% |
| Return on Invested Capital (ROIC) | 1.68% |
| Return on Capital Employed (ROCE) | 1.93% |
| Revenue Per Employee | $288,291 |
| Profits Per Employee | $11,194 |
| Employee Count | 134 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 2.73 |
Taxes
In the past 12 months, BrainsWay has paid $186,000 in taxes.
| Income Tax | 186,000 |
| Effective Tax Rate | 11.03% |
Stock Price Statistics
The stock price has increased by +66.93% in the last 52 weeks. The beta is 0.45, so BrainsWay's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | +66.93% |
| 50-Day Moving Average | 10.15 |
| 200-Day Moving Average | 8.39 |
| Relative Strength Index (RSI) | 51.17 |
| Average Volume (20 Days) | 72,334 |
Short Selling Information
| Short Interest | 62,975 |
| Short Previous Month | 37,460 |
| Short % of Shares Out | 0.46% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.18 |
Income Statement
In the last 12 months, BrainsWay had revenue of $38.63 million and earned $1.50 million in profits. Earnings per share was $0.04.
| Revenue | 38.63M |
| Gross Profit | 28.81M |
| Operating Income | 1.14M |
| Pretax Income | 778,000 |
| Net Income | 1.50M |
| EBITDA | 2.28M |
| EBIT | 1.14M |
| Earnings Per Share (EPS) | $0.04 |
Full Income StatementBalance Sheet
| Cash & Cash Equivalents | 48.13M |
| Total Debt | n/a |
| Net Cash | 48.13M |
| Net Cash Per Share | $1.45 |
| Equity (Book Value) | 44.03M |
| Book Value Per Share | 1.33 |
| Working Capital | 44.64M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $9.28 million and capital expenditures -$3.31 million, giving a free cash flow of $5.97 million.
| Operating Cash Flow | 9.28M |
| Capital Expenditures | -3.31M |
| Free Cash Flow | 5.97M |
| FCF Per Share | $0.18 |
Full Cash Flow StatementMargins
Gross margin is 74.57%, with operating and profit margins of 2.96% and 3.88%.
| Gross Margin | 74.57% |
| Operating Margin | 2.96% |
| Pretax Margin | 4.36% |
| Profit Margin | 3.88% |
| EBITDA Margin | 5.91% |
| EBIT Margin | 2.96% |
| FCF Margin | 15.44% |
Dividends & Yields
BrainsWay does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.64% |
| Shareholder Yield | -1.64% |
| Earnings Yield | 0.70% |
| FCF Yield | 2.78% |
Analyst Forecast
The average price target for BrainsWay is $13.17, which is 22.51% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.17 |
| Price Target Difference | 22.51% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BrainsWay has an Altman Z-Score of 1.54 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.54 |
| Piotroski F-Score | 6 |